ID   NPTN_RAT                Reviewed;         393 AA.
AC   P97546; P97547; Q6IRE8;
DT   10-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   15-JUN-2010, sequence version 2.
DT   24-JUL-2024, entry version 166.
DE   RecName: Full=Neuroplastin;
DE   AltName: Full=Glycoprotein 55/65;
DE            Short=gp55/65;
DE   AltName: Full=Stromal cell-derived receptor 1;
DE            Short=SDR-1;
DE   Flags: Precursor;
GN   Name=Nptn; Synonyms=Sdfr1, Sdr1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY,
RP   DEVELOPMENTAL STAGE, AND GLYCOSYLATION.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8995369; DOI=10.1074/jbc.272.2.821;
RA   Langnaese K., Beesley P.W., Gundelfinger E.D.;
RT   "Synaptic membrane glycoproteins gp65 and gp55 are new members of the
RT   immunoglobulin superfamily.";
RL   J. Biol. Chem. 272:821-827(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 150-159; 186-194; 209-226; 235-243; 245-271; 288-293
RP   AND 363-379 (ISOFORM 1), AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [4]
RP   TISSUE SPECIFICITY.
RA   Lopez N.D., Kinoshita A., Taniwaki M., Tada H., Shirozu M., Nakano T.,
RA   Tashiro K., Honjo T.;
RT   "Isoform specific expression of the SDR-1 protein, alpha and beta in
RT   subregions of adult rodent brain.";
RL   Biomed. Res. 20:43-49(1999).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION (ISOFORM 2), AND TISSUE SPECIFICITY (ISOFORM
RP   2).
RX   PubMed=10759566; DOI=10.1073/pnas.080389297;
RA   Smalla K.H., Matthies H., Langnase K., Shabir S., Bockers T.M., Wyneken U.,
RA   Staak S., Krug M., Beesley P.W., Gundelfinger E.D.;
RT   "The synaptic glycoprotein neuroplastin is involved in long-term
RT   potentiation at hippocampal CA1 synapses.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:4327-4332(2000).
RN   [6]
RP   FUNCTION.
RX   PubMed=16925595; DOI=10.1111/j.1471-4159.2006.04123.x;
RA   Empson R.M., Buckby L.E., Kraus M., Bates K.J., Crompton M.R.,
RA   Gundelfinger E.D., Beesley P.W.;
RT   "The cell adhesion molecule neuroplastin-65 inhibits hippocampal long-term
RT   potentiation via a mitogen-activated protein kinase p38-dependent reduction
RT   in surface expression of GluR1-containing glutamate receptors.";
RL   J. Neurochem. 99:850-860(2006).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-196 AND ASN-228, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24090084; DOI=10.1021/pr400783j;
RA   Parker B.L., Thaysen-Andersen M., Solis N., Scott N.E., Larsen M.R.,
RA   Graham M.E., Packer N.H., Cordwell S.J.;
RT   "Site-specific glycan-peptide analysis for determination of N-glycoproteome
RT   heterogeneity.";
RL   J. Proteome Res. 12:5791-5800(2013).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 148-333 (ISOFORM 1), FUNCTION
RP   (ISOFORM 1), FGFR1-BINDING (ISOFORM 1), DISULFIDE BONDS, AND GLYCOSYLATION
RP   AT ASN-170; ASN-228; ASN-283 AND ASN-295.
RX   PubMed=19952283; DOI=10.1096/fj.09-140509;
RA   Owczarek S., Kiryushko D., Larsen M.H., Kastrup J.S., Gajhede M., Sandi C.,
RA   Berezin V., Bock E., Soroka V.;
RT   "Neuroplastin-55 binds to and signals through the fibroblast growth factor
RT   receptor.";
RL   FASEB J. 24:1139-1150(2010).
CC   -!- FUNCTION: Probable homophilic and heterophilic cell adhesion molecule
CC       involved in long term potentiation at hippocampal excitatory synapses
CC       through activation of p38MAPK (PubMed:10759566, PubMed:16925595). May
CC       also regulate neurite outgrowth by activating the FGFR1 signaling
CC       pathway (PubMed:10759566, PubMed:16925595). May play a role in synaptic
CC       plasticity (PubMed:10759566, PubMed:16925595). Also acts as a chaperone
CC       for ATP2B1; stabilizes ATP2B1 and increases its ATPase activity.
CC       Promotes localization of XKR8 at the cell membrane (By similarity).
CC       {ECO:0000250|UniProtKB:Q9Y639, ECO:0000269|PubMed:10759566,
CC       ECO:0000269|PubMed:16925595}.
CC   -!- SUBUNIT: Interacts with ATP2B1; this interaction stabilizes ATP2B1 and
CC       increases ATPase activity; this interaction controls T cell calcium
CC       homeostasis following T cell activation. Interacts with XKR8; promoting
CC       its localization at the cell membrane. {ECO:0000250|UniProtKB:Q9Y639}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Postsynaptic density
CC       {ECO:0000269|PubMed:10759566}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=2; Synonyms=gp65, np65;
CC         IsoId=P97546-2; Sequence=Displayed;
CC       Name=1; Synonyms=gp55, np55;
CC         IsoId=P97546-1; Sequence=VSP_039258, VSP_039259;
CC       Name=3;
CC         IsoId=P97546-3; Sequence=VSP_039258;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is ubiquitously expressed. Isoform 2 is
CC       brain-specific. In brain isoform 2 is highly expressed in hippocampus
CC       and cerebral cortex and weakly in cerebellum and lower brain regions.
CC       In the hippocampus isoform 2 is found in the dentate gyrus and CA1-CA4,
CC       the striatum oriens of CA3 shows the higher level.
CC       {ECO:0000269|PubMed:8995369, ECO:0000269|Ref.4}.
CC   -!- DEVELOPMENTAL STAGE: Isoform 1 is detectable at all developmental
CC       stages starting from postnatal day 1. Isoform 2 is low at postnatal day
CC       1, increases steadily until postnatal days 20-25 and then declines to
CC       an intermediate level. {ECO:0000269|PubMed:8995369}.
CC   -!- DOMAIN: Some isoforms lack the first Ig-like domain which may confer
CC       homophilic adhesion activity. However, they can bind and activate
CC       FGFR1.
CC   -!- PTM: Isoform 1 and isoform 2 are N-glycosylated.
CC       {ECO:0000269|PubMed:19952283, ECO:0000269|PubMed:8995369}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X99337; CAA67711.1; -; mRNA.
DR   EMBL; X99338; CAA67712.1; -; mRNA.
DR   EMBL; BC070947; AAH70947.1; -; mRNA.
DR   RefSeq; NP_062253.1; NM_019380.1. [P97546-2]
DR   RefSeq; XP_006243236.1; XM_006243174.3.
DR   RefSeq; XP_008764552.1; XM_008766330.2.
DR   PDB; 2WV3; X-ray; 1.95 A; A=148-333.
DR   PDBsum; 2WV3; -.
DR   AlphaFoldDB; P97546; -.
DR   SMR; P97546; -.
DR   BioGRID; 248557; 1.
DR   IntAct; P97546; 1.
DR   MINT; P97546; -.
DR   STRING; 10116.ENSRNOP00000012091; -.
DR   GlyCosmos; P97546; 6 sites, 35 glycans.
DR   GlyGen; P97546; 6 sites, 35 N-linked glycans (2 sites).
DR   iPTMnet; P97546; -.
DR   PhosphoSitePlus; P97546; -.
DR   SwissPalm; P97546; -.
DR   jPOST; P97546; -.
DR   PaxDb; 10116-ENSRNOP00000012091; -.
DR   GeneID; 56064; -.
DR   KEGG; rno:56064; -.
DR   UCSC; RGD:620296; rat. [P97546-2]
DR   AGR; RGD:620296; -.
DR   CTD; 27020; -.
DR   RGD; 620296; Nptn.
DR   VEuPathDB; HostDB:ENSRNOG00000009029; -.
DR   eggNOG; ENOG502QPKN; Eukaryota.
DR   HOGENOM; CLU_058449_1_1_1; -.
DR   InParanoid; P97546; -.
DR   OrthoDB; 4092110at2759; -.
DR   PhylomeDB; P97546; -.
DR   EvolutionaryTrace; P97546; -.
DR   PRO; PR:P97546; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000009029; Expressed in cerebellum and 20 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0001772; C:immunological synapse; ISS:UniProtKB.
DR   GO; GO:0060077; C:inhibitory synapse; IDA:RGD.
DR   GO; GO:0016020; C:membrane; TAS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0045211; C:postsynaptic membrane; TAS:HGNC-UCL.
DR   GO; GO:0048787; C:presynaptic active zone membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:HGNC-UCL.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO.
DR   GO; GO:0097060; C:synaptic membrane; IDA:RGD.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IDA:HGNC-UCL.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:RGD.
DR   GO; GO:0005105; F:type 1 fibroblast growth factor receptor binding; IDA:UniProtKB.
DR   GO; GO:1904861; P:excitatory synapse assembly; ISO:RGD.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IDA:HGNC-UCL.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IDA:UniProtKB.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0001818; P:negative regulation of cytokine production; ISS:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:RGD.
DR   GO; GO:0045743; P:positive regulation of fibroblast growth factor receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0048170; P:positive regulation of long-term neuronal synaptic plasticity; IMP:HGNC-UCL.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; IMP:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB.
DR   GO; GO:1903829; P:positive regulation of protein localization; IMP:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; TAS:HGNC-UCL.
DR   GO; GO:1902683; P:regulation of receptor localization to synapse; ISO:RGD.
DR   GO; GO:0050808; P:synapse organization; ISO:RGD.
DR   GO; GO:0099557; P:trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission; IDA:SynGO.
DR   GO; GO:0008542; P:visual learning; IDA:RGD.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 3.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   PANTHER; PTHR10075; BASIGIN RELATED; 1.
DR   PANTHER; PTHR10075:SF105; NEUROPLASTIN; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF13927; Ig_3; 1.
DR   PIRSF; PIRSF000615; TyrPK_CSF1-R; 1.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 2.
DR   SUPFAM; SSF48726; Immunoglobulin; 3.
DR   PROSITE; PS50835; IG_LIKE; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell membrane;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Membrane; Neurogenesis; Reference proteome; Repeat;
KW   Signal; Synapse; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000250"
FT   CHAIN           29..393
FT                   /note="Neuroplastin"
FT                   /id="PRO_0000394472"
FT   TOPO_DOM        29..338
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        339..359
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y639"
FT   TOPO_DOM        360..393
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          29..134
FT                   /note="Ig-like 1"
FT   DOMAIN          148..234
FT                   /note="Ig-like 2"
FT   DOMAIN          237..327
FT                   /note="Ig-like 3"
FT   REGION          149..161
FT                   /note="Narpin; mediates binding with FGFR1 and has
FT                   antidepressant-like activity"
FT   REGION          366..393
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        170
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19952283"
FT   CARBOHYD        196
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   CARBOHYD        228
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19952283,
FT                   ECO:0007744|PubMed:24090084"
FT   CARBOHYD        283
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19952283"
FT   CARBOHYD        295
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19952283"
FT   CARBOHYD        316
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        52..116
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        169..217
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:19952283"
FT   DISULFID        258..315
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:19952283"
FT   VAR_SEQ         31..147
FT                   /note="AGFVKSPMSETKLTGDAFELYCDVVGSPTPEIQWWYAEVNRAESFRQLWDGA
FT                   RKRRVTVNTAYGSNGVSVLRITRLTLEDSGTYECRASNDPKRNDLRQNPSITWIRAQAT
FT                   ISVLQK -> E (in isoform 1 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:8995369"
FT                   /id="VSP_039258"
FT   VAR_SEQ         370
FT                   /note="D -> DDDEP (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:8995369"
FT                   /id="VSP_039259"
FT   STRAND          149..152
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          161..163
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          165..173
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          178..185
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          198..206
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   HELIX           209..211
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          213..221
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          224..234
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          238..242
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          244..249
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          254..261
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          267..274
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          277..280
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          288..292
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          294..301
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   TURN            306..308
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          311..318
FT                   /evidence="ECO:0007829|PDB:2WV3"
FT   STRAND          323..333
FT                   /evidence="ECO:0007829|PDB:2WV3"
SQ   SEQUENCE   393 AA;  43932 MW;  F11C6B9DF3A6D69A CRC64;
     MSGSSLPGAL ALSLLLVSGS LLPGPGAAQN AGFVKSPMSE TKLTGDAFEL YCDVVGSPTP
     EIQWWYAEVN RAESFRQLWD GARKRRVTVN TAYGSNGVSV LRITRLTLED SGTYECRASN
     DPKRNDLRQN PSITWIRAQA TISVLQKPRI VTSEEVIIRD SLLPVTLQCN LTSSSHTLMY
     SYWTKNGVEL TATRKNASNM EYRINKPRAE DSGEYHCVYH FVSAPKANAT IEVKAAPDIT
     GHKRSENKNE GQDAMMYCKS VGYPHPEWMW RKKENGVFEE ISNSSGRFFI INKENYTELN
     IVNLQITEDP GEYECNATNS IGSASVSTVL RVRSHLAPLW PFLGILAEII ILVVIIVVYE
     KRKRPDEVPD AGPMKTNSTN NHKDKNLRQR NTN
//
